SCHRODER INVESTMENT MANAGEMENT GROUP
Position in RDY — Dr Reddys Laboratories Ltd
CIK 1086619
London, X0
Position in RDY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$23,450,672
+$20,940,513 QoQ
Shares Held
1,618,404
+793.0% QoQ
Ownership
0.194%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#20
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $225,719,959 across 11 Drug Manufacturers - Specialty & Generic names. RDY ranks #4 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,280,484 | $77,262,797 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
72,306 | $39,177,559 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
1,129,781 | $39,169,506 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
This page
|
1,618,404 | $23,450,672 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
368,017 | $17,116,470 | |
| 6 | HCM |
HUTCHMED (China) Ltd
|
1,477,494 | $15,897,835 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
333,656 | $8,211,273 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
16,253 | $2,739,280 |
All Filings in RDY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,450,672 | 1,618,404 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,510,159 | 181,239 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,871,684 | 133,311 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,968,817 | 140,831 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,958,982 | 329,939 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,921,675 | 297,322 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,429,923 | 407,215 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,277,422 | 79,011 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,278,798 | 121,785 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $16,331,815 | 222,656 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $18,553,714 | 266,653 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,041,532 | 150,165 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,836,663 | 92,484 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,666,258 | 46,834 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,802,244 | 34,826 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,745,642 | 33,352 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,492,206 | 26,940 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $12,299,275 | 220,694 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $57,684,619 | 881,893 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $22,661,162 | 347,884 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $66,327,851 | 902,297 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $15,659,115 | 255,076 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $29,928,254 | 419,810 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $33,026,322 | 474,789 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $29,793,421 | 562,034 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $21,338,561 | 529,099 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||